Publications

Overall and gender-specific effects of intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali: a three-group open label randomized controlled trial.

Maiga, H; OPONDO, C; CHICO, RM; Cohee, LM; Sagara, I; Djimde, A;

2022

(2022).(4) 0901 107

Prevalence of sulfadoxine-pyrimethamine resistance markers of plasmodium falciparum among pregnant women in an area of high malaria transmission: Nchelenge, Zambia.

CHAPONDA, M; Mwanza, S; Hachizovu, S; Nambozi, M; Gwasupika, J; Chaponda, EN; CHANDRAMOHAN, D; CHICO, RM;

2022

American Journal of Tropical Medicine and Hygiene, (2022).107 4

Global estimates of pregnancies at risk of Plasmodium falciparum and P. vivax infection in 2020 and changes in risk patterns since 2000.

GORE-LANGTON, G; Cano, J; SIMPSON, H; Tatem, A; Tejedor‐Garavito, N; Wigley, AS; Carioli, A; Gething, PW; Weiss, DJ; CHANDRAMOHAN, D; Walker, PG T; Cairns, ME; CHICO, RM;

2022

(2022).(4) 0928 107

Symposium: New Dual-AI Nets for Malaria Control in Settings of Vector Resistance: A Review of the Current Evidence.

ACCROMBESSI, M; COOK, J; PROTOPOPOFF, N;

2022

(2022).

Assessing seroprevalence and associated risk factors for multiple infectious diseases in Sabah, Malaysia using serological multiplex bead assays.

Chan, YL; PATTERSON, CL; Priest, JW; Stresman, G; William, T; Chua, TH; TETTEH, K; Lammie, P; DRAKELEY, C; Fornace, KM;

2022

Frontiers in public health, (2022).10, 10.3389/fpubh.2022.924316.

Linear and conformational determinants of visceral leishmaniasis diagnostic antigens rK28 and rK39.

SIMONSON, P; BHATTACHARYYA, T; El-Safi, S; MILES, MA;

2022

Parasites & vectors, (2022).15 1 10.1186/s13071-022-05495-1.

G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.

Kheang, ST; Ridley, R; Ngeth, E; Ir, P; Ngor, P; Sovannaroth, S; Lek, D; Phon, S; Kak, N; YEUNG, S;

2022

PLoS One, (2022).17 10 10.1371/journal.pone.0275822.

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.

MANNO, D; Bangura, A; Baiden, F; Kamara, AB; AYIEKO, P; Kallon, J; Foster, J; Conteh, M; CONNOR, NE; Koroma, B; Njie, Y; Borboh, P; Keshinro, B; Lawal, BJ; KROMA, MT; Otieno, GT; Deen, AT; CHOI, EM-L; BALAMI, AD; Gaddah, A; McLean, C; Luhn, K; Adetola, HH; Deen, GF; Samai, M; ... WATSON-JONES, D.

2022

The Lancet. Infectious diseases, (2022).23 3 10.1016/S1473-3099(22)00594-1.

Protective efficacy of holed and aging PBO-pyrethroid synergist-treated nets on malaria infection prevalence in north-western Tanzania.

LUKOLE, E; COOK, J; Mosha, JF; MESSENGER, LA; ROWLAND, M; KLEINSCHMIDT, I; Charlwood, JD; Mosha, FW; Manjurano, A; Wright, A; PROTOPOPOFF, N;

2022

PLOS Global Public Health, (2022).2 10 10.1371/journal.pgph.0000453.

Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for Plasmodium knowlesi and P. falciparum.

Tan, AF; Sakam, SS B; Rajahram, GS; William, T; Abd Rachman Isnadi, MF; Daim, S; Barber, BE; Kho, S; SUTHERLAND, CJ; Anstey, NM; Yerlikaya, S; VAN SCHALKWYK, DA; Grigg, MJ;

2022

Frontiers in cellular and infection microbiology, (2022).12, 10.3389/fcimb.2022.1023219.